The Delhi High Court on Tuesday disposed of a public interest litigation (PIL) raising alarm over the off-label and ...

VK2735 shows strong early weight loss data, positioning Viking Therapeutics as a potential third major player in the booming GLP-1 obesity drug market. Learn more on VKTX stock here.

New rules are reshaping the telehealth market for GLP-1s like Ozempic and Wegovy, potentially impacting access to these drugs ...

Biocon has scrapped its plans to introduce generic versions of Novo Nordisk's Ozempic and Wegovy in China, citing intense ...

Acknowledging her efforts keeps her feelings from getting hurt, and being honest about what you can and can’t offer right now ...

Top executives ignored warnings that the company was not sufficiently prepared for the launch of its weight-loss drug Wegovy, ...

Julian Melchiorri is an entrepreneur and innovator recognised for his pioneering work on photosynthesis and biomimicry. He is ...

As obesity management draws awareness and weight-loss injections are launched in India, hospitals are offering customised ...

Novo Nordisk A/S (NYSE:NVO) is one of the 12 stocks that will make you rich in 10 years. On June 23, the company discontinued ...

Joie Armstrong asked her doctor about taking a GLP-1 medication to help her lose weight six times before she got a prescription, and then was denied coverage by her insurance company. Adrian, a ...